DBVT
DBV Technologies
NASDAQ: DBVT · HEALTHCARE · BIOTECHNOLOGY
$21.00
+3.45% today
Updated 2026-04-30
Market cap
$1.17B
P/E ratio
—
P/S ratio
207.92x
EPS (TTM)
$-5.25
Dividend yield
—
52W range
$8 – $26
Volume
0.2M
DBV Technologies (DBVT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10.36M | $-17.80M | $-24.31M | $-32.45M | $-31.93M | $-65.68M | $-160.91M | $-186.74M | $-148.35M | $-165.61M | $-108.24M | $-55.70M | $-79.65M | $-104.47M | $-121.18M |
| Capital expenditures | $1.21M | $616727.00 | $2.15M | $1.53M | $5.38M | $9.05M | $10.62M | $6.49M | $5.60M | $2.76M | $918000.00 | $754000.00 | $677000.00 | $2.34M | $533642.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.18M | $5.45M | $9.26M | $7.32M | $12.43M | $37.90M | $43.33M | $35.41M | $17.24M | $-1.13M | $3.12M | $5.03M | $6.02M | $4.62M | $5.39M |
| Free cash flow | $-11.57M | $-18.42M | $-26.46M | $-33.99M | $-37.31M | $-74.73M | $-171.53M | $-193.23M | $-153.94M | $-168.37M | $-109.16M | $-56.45M | $-80.33M | $-106.81M | $-121.71M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $4.94M | $1.03M | $0.00 | $0.00 | $0.00 | $0.00 | $303000.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |